{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:04:34Z","timestamp":1791072274792,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Toxoplasmosis is a worldwide infection caused by the protozoan parasite <jats:italic>Toxoplasma gondii<\/jats:italic>, which causes chorioretinitis and neurological defects in congenitally infected newborns or immunodeficient patients. The efficacy of the current treatment is limited, primarily by serious host toxicity. In recent years, research has focused on the development of new drugs against <jats:italic>T. gondii<\/jats:italic>. \u03b2-Carbolines (\u03b2Cs), such as harmane, norharmane and harmine, are a group of naturally occurring alkaloids that show microbicidal activity. In this work, harmane, norharmane and harmine were tested against <jats:italic>T. gondii<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Findings<\/jats:title>\n            <jats:p>The treatment of extracellular tachyzoites with harmane, norharmane and harmine showed a 2.5 to 3.5-fold decrease in the invasion rates at doses of 40 \u03bcM (harmane and harmine) and 2.5 \u03bcM (norharmane) compared with the untreated parasites. Furthermore, an effect on the replication rate could also be observed with a decrease of 1 (harmane) and 2 (norharmane and harmine) division rounds at doses of 5 to 12.5 \u03bcM. In addition, the treated parasites presented either delayed or no monolayer lysis compared with the untreated parasites.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The three \u03b2C alkaloids studied (norharmane, harmane and harmine) exhibit anti-<jats:italic>T. gondii<\/jats:italic> effects as evidenced by the partial inhibition of parasite invasion and replication. A dose\u2013response effect was observed at a relatively low drug concentration (&lt; 40 \u03bcM), at which no cytotoxic effect was observed on the host cell line (Vero).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-0500-6-193","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T16:14:14Z","timestamp":1368202454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["In vitro evaluation of \u03b2-carboline alkaloids as potential anti-Toxoplasma agents"],"prefix":"10.1186","volume":"6","author":[{"given":"Maria L","family":"Alomar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico AO","family":"Rasse-Suriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustina","family":"Ganuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica M","family":"C\u00f3ceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco M","family":"Cabrerizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio O","family":"Angel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,10]]},"reference":[{"issue":"12\u201313","key":"2203_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","volume":"30","author":"AM Tenter","year":"2000","unstructured":"Tenter AM, Heckeroth AR, Weiss LM: Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000, 30 (12\u201313): 1217-1258.","journal-title":"Int J Parasitol"},{"issue":"2","key":"2203_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.actatropica.2011.10.018","volume":"121","author":"Y Carlier","year":"2012","unstructured":"Carlier Y, Truyens C, Deloron P, Peyron F: Congenital parasitic infections: a review. Acta Trop. 2012, 121 (2): 55-70. 10.1016\/j.actatropica.2011.10.018.","journal-title":"Acta Trop"},{"issue":"3","key":"2203_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s007870170027","volume":"10","author":"A Brynska","year":"2001","unstructured":"Brynska A, Tomaszewicz-Libudzic E, Wolanczyk T: Obsessive-compulsive disorder and acquired toxoplasmosis in two children. Eur Child Adolesc Psychiatry. 2001, 10 (3): 200-204. 10.1007\/s007870170027.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1\u20132","key":"2203_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.psychres.2009.12.013","volume":"177","author":"O Miman","year":"2010","unstructured":"Miman O, Mutlu EA, Ozcan O, Atambay M, Karlidag R, Unal S: Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder?. Psychiatry Res. 2010, 177 (1\u20132): 263-265.","journal-title":"Psychiatry Res"},{"issue":"11","key":"2203_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1365-3024.2009.01131.x","volume":"31","author":"RH Yolken","year":"2009","unstructured":"Yolken RH, Dickerson FB, Fuller Torrey E: Toxoplasma and schizophrenia. Parasite Immunol. 2009, 31 (11): 706-715. 10.1111\/j.1365-3024.2009.01131.x.","journal-title":"Parasite Immunol"},{"issue":"2","key":"2203_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.meegid.2012.01.013","volume":"12","author":"M Vittecoq","year":"2012","unstructured":"Vittecoq M, Elguero E, Lafferty KD, Roche B, Brodeur J, Gauthier-Clerc M, Misse D, Thomas F: Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France. Infect Genet Evol. 2012, 12 (2): 496-498. 10.1016\/j.meegid.2012.01.013.","journal-title":"Infect Genet Evol"},{"issue":"2","key":"2203_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","volume":"15","author":"BJ Luft","year":"1992","unstructured":"Luft BJ, Remington JS: Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992, 15 (2): 211-222. 10.1093\/clinids\/15.2.211.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2203_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/00002030-199303000-00001","volume":"7","author":"SY Wong","year":"1993","unstructured":"Wong SY, Remington JS: Biology of Toxoplasma gondii. AIDS. 1993, 7 (3): 299-316. 10.1097\/00002030-199303000-00001.","journal-title":"AIDS"},{"key":"2203_CR9","doi-asserted-by":"publisher","first-page":"D391","DOI":"10.2741\/Weiss","volume":"5","author":"LM Weiss","year":"2000","unstructured":"Weiss LM, Kim K: The development and biology of bradyzoites of Toxoplasma gondii. Front Biosci. 2000, 5: D391-405. 10.2741\/Weiss.","journal-title":"Front Biosci"},{"issue":"3","key":"2203_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1517\/13543776.2012.668886","volume":"22","author":"JB Rodriguez","year":"2012","unstructured":"Rodriguez JB, Szajnman SH: New antibacterials for the treatment of toxoplasmosis; a patent review. Expert Opin Ther Pat. 2012, 22 (3): 311-333. 10.1517\/13543776.2012.668886.","journal-title":"Expert Opin Ther Pat"},{"issue":"10","key":"2203_CR11","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1586\/eri.12.100","volume":"10","author":"L Vanagas","year":"2012","unstructured":"Vanagas L, Jeffers V, Bogado SS, Dalmasso MC, Sullivan WJ, Angel SO: Toxoplasma histone acetylation remodelers as novel drug targets. Expert Rev Anti Infect Ther. 2012, 10 (10): 1189-1201. 10.1586\/eri.12.100.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2203_CR12","volume-title":"A review of recent patents on the protozoan parasite HSP90 as a drug target","author":"SO Angel","year":"2012","unstructured":"Angel SO, Matrajt M, Echeverria PC: A review of recent patents on the protozoan parasite HSP90 as a drug target. 2012, Biotechnol: Recent Pat"},{"issue":"3","key":"2203_CR13","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.fct.2009.12.019","volume":"48","author":"T Herraiz","year":"2010","unstructured":"Herraiz T, Gonzalez D, Ancin-Azpilicueta C, Aran VJ: Guillen H: beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem Toxicol. 2010, 48 (3): 839-845. 10.1016\/j.fct.2009.12.019.","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"2203_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jchromb.2003.10.044","volume":"802","author":"W Pfau","year":"2004","unstructured":"Pfau W, Skog K: Exposure to beta-carbolines norharman and harman. J Chromatogr B Analyt Technol Biomed Life Sci. 2004, 802 (1): 115-126. 10.1016\/j.jchromb.2003.10.044.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"2203_CR15","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1074\/jbc.275.4.2455","volume":"275","author":"K Pari","year":"2000","unstructured":"Pari K, Sundari CS, Chandani S: Balasubramanian D: beta-carbolines that accumulate in human tissues may serve a protective role against oxidative stress. J Biol Chem. 2000, 275 (4): 2455-2462. 10.1074\/jbc.275.4.2455.","journal-title":"J Biol Chem"},{"issue":"1","key":"2203_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0924-977X(01)00143-2","volume":"12","author":"R Spijkerman","year":"2002","unstructured":"Spijkerman R, van den Eijnden R, van de Mheen D, Bongers I, Fekkes D: The impact of smoking and drinking on plasma levels of norharman. Eur Neuropsychopharmacol. 2002, 12 (1): 61-71. 10.1016\/S0924-977X(01)00143-2.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"9","key":"2203_CR17","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0300-9084(85)80289-3","volume":"67","author":"J Torreilles","year":"1985","unstructured":"Torreilles J, Guerin MC, Previero A: Simple compounds with high pharmacologic potential: beta-carbolines. Origins, syntheses, biological properties. Biochimie. 1985, 67 (9): 929-947. 10.1016\/S0300-9084(85)80289-3.","journal-title":"Biochimie"},{"issue":"24","key":"2203_CR18","doi-asserted-by":"publisher","first-page":"6648","DOI":"10.1021\/jp902105x","volume":"113","author":"MM Gonzalez","year":"2009","unstructured":"Gonzalez MM, Arnbjerg J, Denofrio MP, Erra-Balsells R, Ogilby PR, Cabrerizo FM: One- and two-photon excitation of beta-carbolines in aqueous solution: pH-dependent spectroscopy, photochemistry, and photophysics. J Phys Chem A. 2009, 113 (24): 6648-6656. 10.1021\/jp902105x.","journal-title":"J Phys Chem A"},{"issue":"1","key":"2203_CR19","first-page":"19","volume":"5","author":"AM Sobhani","year":"2002","unstructured":"Sobhani AM, Ebrahimi SA, Mahmoudian M: An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids. J Pharm Pharm Sci. 2002, 5 (1): 19-23.","journal-title":"J Pharm Pharm Sci"},{"issue":"4","key":"2203_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2174\/092986707779940998","volume":"14","author":"R Cao","year":"2007","unstructured":"Cao R, Peng W, Wang Z, Xu A: beta-Carboline alkaloids: biochemical and pharmacological functions. Curr Med Chem. 2007, 14 (4): 479-500. 10.2174\/092986707779940998.","journal-title":"Curr Med Chem"},{"issue":"2","key":"2203_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s004360100454","volume":"88","author":"N Azas","year":"2002","unstructured":"Azas N, Laurencin N, Delmas F, Di GC, Gasquet M, Laget M, Timon-David P: Synergistic in vitro antimalarial activity of plant extracts used as traditional herbal remedies in Mali. Parasitol Res. 2002, 88 (2): 165-171. 10.1007\/s004360100454.","journal-title":"Parasitol Res"},{"issue":"7","key":"2203_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ptr.1025","volume":"16","author":"C Ancolio","year":"2002","unstructured":"Ancolio C, Azas N, Mahiou V, Ollivier E, Di Giorgio C, Keita A, Timon-David P, Balansard G: Antimalarial activity of extracts and alkaloids isolated from six plants used in traditional medicine in Mali and Sao Tome. Phytother Res. 2002, 16 (7): 646-649. 10.1002\/ptr.1025.","journal-title":"Phytother Res"},{"issue":"5","key":"2203_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/pca.927","volume":"17","author":"J Fiot","year":"2006","unstructured":"Fiot J, Jansen O, Akhmedjanova V, Angenot L, Balansard G, Ollivier E: HPLC quantification of alkaloids from Haplophyllum extracts and comparison with their cytotoxic properties. Phytochem Anal. 2006, 17 (5): 365-369. 10.1002\/pca.927.","journal-title":"Phytochem Anal"},{"issue":"3\u20134","key":"2203_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.exppara.2004.04.002","volume":"106","author":"C Di Giorgio","year":"2004","unstructured":"Di Giorgio C, Delmas F, Ollivier E, Elias R, Balansard G, Timon-David P: In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum. Exp Parasitol. 2004, 106 (3\u20134): 67-74.","journal-title":"Exp Parasitol"},{"issue":"3","key":"2203_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/10611860410001712696","volume":"12","author":"S Lala","year":"2004","unstructured":"Lala S, Pramanick S, Mukhopadhyay S, Bandyopadhyay S, Basu MK: Harmine: evaluation of its antileishmanial properties in various vesicular delivery systems. J Drug Target. 2004, 12 (3): 165-175. 10.1080\/10611860410001712696.","journal-title":"J Drug Target"},{"issue":"1","key":"2203_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0742-8413(98)10069-5","volume":"122","author":"P Rivas","year":"1999","unstructured":"Rivas P, Cassels BK, Morello A, Repetto Y: Effects of some beta-carboline alkaloids on intact Trypanosoma cruzi epimastigotes. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1999, 122 (1): 27-31. 10.1016\/S0742-8413(98)10069-5.","journal-title":"Comp Biochem Physiol C Pharmacol Toxicol Endocrinol"},{"key":"2203_CR27","volume-title":"Curr Pharm Des","author":"AK Rochani","year":"2012","unstructured":"Rochani AK, Singh M, Tatu U: Heat Shock Protein 90 Inhibitors as Broad Spectrum Anti-infectives. Curr Pharm Des. 2012"},{"issue":"9","key":"2203_CR28","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1021\/jm901796s","volume":"53","author":"D Shahinas","year":"2010","unstructured":"Shahinas D, Liang M, Datti A, Pillai DR: A repurposing strategy identifies novel synergistic inhibitors of Plasmodium falciparum heat shock protein 90. J Med Chem. 2010, 53 (9): 3552-3557. 10.1021\/jm901796s.","journal-title":"J Med Chem"},{"issue":"8","key":"2203_CR29","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1128\/AAC.00328-12","volume":"56","author":"D Shahinas","year":"2012","unstructured":"Shahinas D, Macmullin G, Benedict C, Crandall I, Pillai DR: Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin. Antimicrob Agents Chemother. 2012, 56 (8): 4207-4213. 10.1128\/AAC.00328-12.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2203_CR30","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1021\/ja002073o","volume":"123","author":"KA El Sayed","year":"2001","unstructured":"El Sayed KA, Kelly M, Kara UA, Ang KK, Katsuyama I, Dunbar DC, Khan AA, Hamann MT: New manzamine alkaloids with potent activity against infectious diseases. J Am Chem Soc. 2001, 123 (9): 1804-1808. 10.1021\/ja002073o.","journal-title":"J Am Chem Soc"},{"issue":"7","key":"2203_CR31","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0960-894X(02)00094-X","volume":"12","author":"Y Song","year":"2002","unstructured":"Song Y, Wang J, Teng SF, Kesuma D, Deng Y, Duan J, Wang JH, Qi RZ, Sim MM: \u03b2-Carbolines as specific inhibitors of cyclin-Dependent kinases. Bioorg Med Chem Lett. 2002, 12 (7): 1129-1132. 10.1016\/S0960-894X(02)00094-X.","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"2203_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbrc.2004.03.019","volume":"317","author":"Y Song","year":"2004","unstructured":"Song Y, Kesuma D, Wang J, Deng Y, Duan J, Wang JH, Qi RZ: Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine. Biochem Biophys Res Commun. 2004, 317 (1): 128-132. 10.1016\/j.bbrc.2004.03.019.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"2203_CR33","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1039\/b822173a","volume":"8","author":"MM Gonzalez","year":"2009","unstructured":"Gonzalez MM, Salum ML, Gholipour Y, Cabrerizo FM, Erra-Balsells R: Photochemistry of norharmane in aqueous solution. Photochem Photobiol Sci. 2009, 8 (8): 1139-1149. 10.1039\/b822173a.","journal-title":"Photochem Photobiol Sci"},{"issue":"4\u20135","key":"2203_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.etp.2007.12.003","volume":"60","author":"J Jimenez","year":"2008","unstructured":"Jimenez J, Riveron-Negrete L, Abdullaev F, Espinosa-Aguirre J, Rodriguez-Arnaiz R: Cytotoxicity of the beta-carboline alkaloids harmine and harmaline in human cell assays in vitro. Exp Toxicol Pathol. 2008, 60 (4\u20135): 381-389.","journal-title":"Exp Toxicol Pathol"},{"issue":"6","key":"2203_CR35","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1371\/journal.ppat.0030078","volume":"3","author":"B Striepen","year":"2007","unstructured":"Striepen B, Jordan CN, Reiff S, van Dooren GG: Building the perfect parasite: cell division in apicomplexa. PLoS Pathog. 2007, 3 (6): e78-10.1371\/journal.ppat.0030078.","journal-title":"PLoS Pathog"},{"issue":"8","key":"2203_CR36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrmicro1465","volume":"4","author":"J Baum","year":"2006","unstructured":"Baum J, Papenfuss AT, Baum B, Speed TP, Cowman AF: Regulation of apicomplexan actin-based motility. Nat Rev Microbiol. 2006, 4 (8): 621-628. 10.1038\/nrmicro1465.","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"2203_CR37","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0968-0896(00)00073-0","volume":"8","author":"G Bringmann","year":"2000","unstructured":"Bringmann G, Feineis D, Bruckner R, Blank M, Peters K, Peters EM, Reichmann H, Janetzky B, Grote C, Clement HW: Bromal-derived tetrahydro-beta-carbolines as neurotoxic agents: chemistry, impairment of the dopamine metabolism, and inhibitory effects on mitochondrial respiration. Bioorg Med Chem. 2000, 8 (6): 1467-1478. 10.1016\/S0968-0896(00)00073-0.","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"2203_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0166-6851(01)00284-5","volume":"115","author":"JR Radke","year":"2001","unstructured":"Radke JR, Striepen B, Guerini MN, Jerome ME, Roos DS, White MW: Defining the cell cycle for the tachyzoite stage of Toxoplasma gondii. Mol Biochem Parasitol. 2001, 115 (2): 165-175. 10.1016\/S0166-6851(01)00284-5.","journal-title":"Mol Biochem Parasitol"},{"issue":"9","key":"2203_CR39","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1039\/c2ob06505c","volume":"10","author":"MM Gonzalez","year":"2012","unstructured":"Gonzalez MM, Vignoni M, Pellon-Maison M, Ales-Gandolfo MA, Gonzalez-Baro MR, Erra-Balsells R, Epe B, Cabrerizo FM: Photosensitization of DNA by beta-carbolines: kinetic analysis and photoproduct characterization. Org Biomol Chem. 2012, 10 (9): 1807-1819. 10.1039\/c2ob06505c.","journal-title":"Org Biomol Chem"},{"issue":"11","key":"2203_CR40","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1039\/c002235g","volume":"8","author":"MM Gonzalez","year":"2010","unstructured":"Gonzalez MM, Pellon-Maison M, Ales-Gandolfo MA, Gonzalez-Baro MR, Erra-Balsells R, Cabrerizo FM: Photosensitized cleavage of plasmidic DNA by norharmane, a naturally occurring beta-carboline. Org Biomol Chem. 2010, 8 (11): 2543-2552. 10.1039\/c002235g.","journal-title":"Org Biomol Chem"},{"issue":"18","key":"2203_CR41","first-page":"5077","volume":"49","author":"YH Hsiang","year":"1989","unstructured":"Hsiang YH, Lihou MG, Liu LF: Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 1989, 49 (18): 5077-5082.","journal-title":"Cancer Res"},{"issue":"21","key":"2203_CR42","first-page":"6919","volume":"50","author":"P D'Arpa","year":"1990","unstructured":"D'Arpa P, Beardmore C, Liu LF: Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res. 1990, 50 (21): 6919-6924.","journal-title":"Cancer Res"},{"issue":"4","key":"2203_CR43","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jmb.2005.05.031","volume":"350","author":"PC Echeverria","year":"2005","unstructured":"Echeverria PC, Matrajt M, Harb OS, Zappia MP, Costas MA, Roos DS, Dubremetz JF, Angel SO: Toxoplasma gondii Hsp90 is a potential drug target whose expression and subcellular localization are developmentally regulated. J Mol Biol. 2005, 350 (4): 723-734. 10.1016\/j.jmb.2005.05.031.","journal-title":"J Mol Biol"},{"issue":"1","key":"2203_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bmc.2010.11.041","volume":"19","author":"J Reniers","year":"2011","unstructured":"Reniers J, Robert S, Frederick R, Masereel B, Vincent S, Wouters J: Synthesis and evaluation of beta-carboline derivatives as potential monoamine oxidase inhibitors. Bioorg Med Chem. 2011, 19 (1): 134-144. 10.1016\/j.bmc.2010.11.041.","journal-title":"Bioorg Med Chem"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-6-193.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:46:19Z","timestamp":1630539979000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-6-193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,10]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2203"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-6-193","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,10]]},"assertion":[{"value":"18 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"193"}}